- Sabila Industrial Originally Certified ISO in January 2003
- No Incidences of Nonconformance Found for Last Two Years - Auditors Stated, "First Time Any Company They Audited Performed at Such a
High Quality Level"
- Company Dedicated to Quality
IRVING, Texas, Sept. 6 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (Pink Sheets: CARN) today announced that its bulk pharmaceutical manufacturing subsidiary, Sabila Industrial, S.A., located in Liberia, Guanacaste, Costa Rica, has completed an annual ISO 9001:2000 re-certification inspection by the European Union's notified body, AENOR Internacional, S.A.U. of Madrid, Spain.
Mr. Jose Zuniga, Carrington's vice president of operations and manager of South American business, stated, "The Chief Inspector representing AENOR Internacional stated that this is the first time any company audited by his team has performed at such a high quality level that no nonconformances with ISO quality systems have been found over a two-year period. We at Carrington, and in particular Sabila Industrial, are delighted that our quality systems are recognized by an EU's notified body. We credit our frequent quality audits in Costa Rica and at our manufacturing facilities in Texas as key to our success."
Mr. Zuniga added, "Using organic certified plant materials, our Costa
Rica plant manufactures the GelSite(R) polymer, the raw material key to the
drug and vaccine delivery technology being developed by Carrington's
biotech subsidiary DelSite Biotechnologies, Inc. GelSite(R) is used to make
the influenza nasal powder vaccine for bird flu (H5N1). Additionally, our
corporate site in Texas uses organic methods on its grounds, our Costa Rica
farming operation is certified organic, and our raw material Manapol(R) is
kosher certified. These certifications and quality systems are not
inexpensive, but they show our dedication to quality. These inspecti
|SOURCE Carrington Laboratories, Inc.|
Copyright©2007 PR Newswire.
All rights reserved